KA
Katherine A. High
Co-founder
About
Co-founder and Head of R&D/Chief Scientific Officer of Spark Therapeutics gene therapy company. Acquired by Roche for $4.3B in 2019. Director of Center for Cellular and Molecular Therapeutics at Children's Hospital Philadelphia.
Comments
No comments yet. Be the first to share your take.
Frequently asked
Who is Katherine A. High?
Co-founder and Head of R&D/Chief Scientific Officer of Spark Therapeutics gene therapy company. Acquired by Roche for $4.3B in 2019. Director of Center for Cellular and Molecular Therapeutics at Children's Hospital Philadelphia.
What is Katherine A. High's current role?
Katherine A. High is currently Co-founder.
Where is Katherine A. High based?
Katherine A. High is based in Philadelphia, United States.
Profile
About Katherine A. High
Katherine A. High is Co-founder. Katherine is a founder of Spark Therapeutics. Based in Philadelphia, United States. This profile tracks their companies, funding activity, and news mentions across the AI ecosystem.